These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 10686083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
    Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK.
    J Neurosci; 2003 Nov 26; 23(34):10982-7. PubMed ID: 14645494
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C, Weiss M, Rostain JC.
    Brain Res; 2007 Oct 24; 1176():37-44. PubMed ID: 17900538
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G, Abarca J, Bustos V, Riquelme E, Noriega V, Moya C, Campusano J.
    J Neurosci Res; 2009 Aug 01; 87(10):2308-18. PubMed ID: 19326433
    [Abstract] [Full Text] [Related]

  • 8. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
    Robinson S, Krentz L, Moore C, Meshul CK.
    Synapse; 2001 Oct 01; 42(1):54-61. PubMed ID: 11668591
    [Abstract] [Full Text] [Related]

  • 9. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M, Manzalini M, Fantin M, Bianchi C, Della Corte L, Morari M.
    J Neurochem; 2005 Apr 01; 93(1):195-205. PubMed ID: 15773919
    [Abstract] [Full Text] [Related]

  • 10. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
    Fantin M, Marti M, Auberson YP, Morari M.
    J Neurochem; 2007 Dec 01; 103(6):2200-11. PubMed ID: 17986236
    [Abstract] [Full Text] [Related]

  • 11. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
    Zeevalk GD, Manzino L, Sonsalla PK.
    Exp Neurol; 2002 Jul 01; 176(1):193-202. PubMed ID: 12093096
    [Abstract] [Full Text] [Related]

  • 12. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M, O'Connor WT, Ungerstedt U, Bianchi C, Fuxe K.
    Neuroscience; 1996 May 01; 72(1):89-97. PubMed ID: 8730708
    [Abstract] [Full Text] [Related]

  • 13. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX, Bergstrom DA, Ruskin DN, Walters JR.
    Synapse; 1998 Sep 01; 30(1):18-29. PubMed ID: 9704877
    [Abstract] [Full Text] [Related]

  • 14. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun 01; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 15. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.
    Zeevalk GD, Derr-Yellin E, Nicklas WJ.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1124-30. PubMed ID: 8531072
    [Abstract] [Full Text] [Related]

  • 16. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L, O'Connor WT, Beggiato S, Tomasini MC, Fuxe K, Tanganelli S, Antonelli T.
    Eur J Neurosci; 2012 Jan 01; 35(2):207-20. PubMed ID: 22211865
    [Abstract] [Full Text] [Related]

  • 17. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation.
    Kreipke CW, Walker PD.
    Synapse; 2004 Jul 01; 53(1):28-35. PubMed ID: 15150738
    [Abstract] [Full Text] [Related]

  • 18. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T, Lee J, Fujita S, Kiguchi M, Matsumoto M, Oi Y, Gionhaku N, Koshikawa N.
    Methods Find Exp Clin Pharmacol; 2005 Jul 01; 27(1):31-7. PubMed ID: 15834457
    [Abstract] [Full Text] [Related]

  • 19. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J, Cepeda C, Hernández-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA, Greengard P, Levine MS.
    J Neurophysiol; 2002 Dec 01; 88(6):3010-20. PubMed ID: 12466426
    [Abstract] [Full Text] [Related]

  • 20. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.